Parkside Financial Bank & Trust’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
HRCM
NAMI
Parkside Financial Bank & Trust's ATRC Position: Q2 2026 in Review
Parkside Financial Bank & Trust reduced its AtriCure (ATRC) stake by 18% in Q2 2026, selling an estimated $957 and leaving 160 shares worth $4.48K. The position accounts for ﹤0.01% of the portfolio, ranked #1929.
Parkside Financial Bank & Trust first reported a position in ATRC in Q1 2025 and has held it in 6 quarters since. The position peaked at $8.5K in Q3 2025. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.
- Parkside Financial Bank & Trust held 160 shares of AtriCure worth $4.48K as of Q2 2026.
- Parkside Financial Bank & Trust sold 34 AtriCure shares in Q2 2026, an estimated $957.
- AtriCure made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #1929 holding.
- Parkside Financial Bank & Trust first reported a position in AtriCure in Q1 2025 and has held it in 6 quarters since.
- Parkside Financial Bank & Trust's AtriCure position peaked at $8.5K in Q3 2025.
- 251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.
Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.